3.28
0.23 (7.54%)
0.23 (7.54%)
Upgrade to Real-Time
Market Closed
Low
1.63
High
10.01
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.23 | 7.54% | 3.28 | 16:00:06 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.03 | 2.94 | 3.29 | 3.28 | 3.05 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.29 | 3.30 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,274 | 2,653,471 | $ 3.0872 | $ 8,191,859 | - | 1.63 - 10.01 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:01:19 | formt | 2,032 | $ 3.30 | USD |
CytoDyn (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.02B | 617.29M | 377.49M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 35.36M | $ - | 0.00% | - | - |
CytoDyn (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.10 | 3.44 | 2.635 | 3.01 | 3,745,656 | 0.18 | 5.81% |
| 1 Month | 2.41 | 4.22 | 2.10 | 3.04 | 4,191,102 | 0.87 | 36.1% |
| 3 Months | 4.94 | 7.70 | 2.00 | 4.01 | 5,073,944 | -1.66 | -33.6% |
| 6 Months | 2.85 | 7.70 | 1.63 | 4.00 | 4,618,453 | 0.43 | 15.09% |
| 1 Year | 2.39 | 10.01 | 1.63 | 4.18 | 5,461,913 | 0.89 | 37.24% |
| 3 Years | 0.5175 | 10.01 | 0.0552 | 3.28 | 2,678,744 | 2.76 | 533.82% |
| 5 Years | 1.25 | 10.01 | 0.0552 | 3.15 | 1,706,991 | 2.03 | 162.4% |
CytoDyn (QB) Description
| CytoDyn Inc. is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of Human Immunodeficiency Virus (HIV), Cancer, and Immunology. |
